Premium
Role of Ventricular Tachycardia Surgery and Catheter Ablation As Complements or Alternatives To the Implantable Cardioverter Defibrillator in the 1990s
Author(s) -
BREITHARDT GUNTER,
BORGGREFE MARTIN,
WIETHOLT DIETMAR,
ISBRUCH FRANK,
BLOCK MICHAEL,
SHENASA MOHAMMAD,
HAMMEL DIETER,
SCHELD HANS H.
Publication year - 1992
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.1992.tb05163.x
Subject(s) - medicine , angiology , cardiac surgery , university hospital , cardiology , cardiothoracic surgery , surgery
Although the implantable cardioverter defibrillator is used increasingly, other nonpharmacological approaches have their indications and merits. Furthermore, as the natural history of ventricular tachyarrhythmias or their underlying structural cardiac abnormality, i.e., coronary artery disease, dilated cardiomyopathy, arrhythmogenic right ventricular disease, etc. change, the mode of therapy may be modified accordingly. Because of the disappointing results of the CAST study in previously asymptomatic patients after myocardial infarction and the evidence that failure of one or two antiarrhythmic drugs tested by programmed ventricular stimulation in patients with documented sustained ventricular tachycardia or fibrillation predicts further drug failure, there will be a significant increase in the use of implantable cardioverters defibrillators in the 1990s. However, care should be taken to avoid inappropriate use of these devices.